LD-2 disclosure · Registration
DENALI THERAPEUTICS
Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.
Client
- Description
- Biopharmaceutical Company
- Location
- California · United States of America
Registrant
- Description
- Law firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Rare Pediatric Disease Priority Review Voucher (PRV) Program Reauthorization; Medicaid policies that impact access to innovative treatments for pediatric rare diseases; rare disease drug development
LobbyistsHEIDE BAJNRAUH · mrs KENDALL BYRUM HUSSEY · RACHEL SHER